Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

Diana Bonderman; Ingrid Pretsch; Regina Steringer-Mascherbauer; Pavel Jansa; Stephan Rosenkranz; Caroline Tufaro; Andja Bojic; Carolyn S P Lam; Reiner Frey; Michael Ochan Kilama; Sigrun Unger; Lothar Roessig; Irene M Lang

doi:10.1378/chest.14-0106

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

Diana Bonderman, Ingrid Pretsch (Co-Autor/-in), Regina Steringer-Mascherbauer, Pavel Jansa, Stephan Rosenkranz, Caroline Tufaro, Andja Bojic, Carolyn S P Lam, Reiner Frey, Michael Ochan Kilama, Sigrun Unger, Lothar Roessig, Irene M Lang

Universitätsklinik für Innere Medizin 2 - Kardiologie, Internistische Intensivmedizin und Notaufnahme

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

186 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	1274-1285
Fachzeitschrift	CHEST
Jahrgang	146
Ausgabenummer	5
DOIs	https://doi.org/10.1378/chest.14-0106
Publikationsstatus	Veröffentlicht - 2014

Zugriff auf Dokument

10.1378/chest.14-0106

Dieses zitieren

Bonderman, D., Pretsch, I., Steringer-Mascherbauer, R., Jansa, P., Rosenkranz, S., Tufaro, C., Bojic, A., Lam, C. S. P., Frey, R., Ochan Kilama, M., Unger, S., Roessig, L., & Lang, I. M. (2014). Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. CHEST , 146(5), 1274-1285. https://doi.org/10.1378/chest.14-0106

Bonderman, Diana ; Pretsch, Ingrid ; Steringer-Mascherbauer, Regina et al. / Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. in: CHEST 2014 ; Jahrgang 146, Nr. 5. S. 1274-1285.

@article{bab9e4e23fc94bbc98b8a09145ad6783,

title = "Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.",

keywords = "PRESERVED EJECTION FRACTION, SOLUBLE GUANYLATE-CYCLASE, ENDOTHELIAL DYSFUNCTION, PHOSPHODIESTERASE-5 INHIBITION, NITRIC-OXIDE, GUIDELINES, COMMUNITY, DIAGNOSIS, GENDER, TARGET",

author = "Diana Bonderman and Ingrid Pretsch and Regina Steringer-Mascherbauer and Pavel Jansa and Stephan Rosenkranz and Caroline Tufaro and Andja Bojic and Lam, {Carolyn S P} and Reiner Frey and {Ochan Kilama}, Michael and Sigrun Unger and Lothar Roessig and Lang, {Irene M}",

note = "the Department of Internal Medicine II (Cardiology) (Dr Pretsch), Paracelsus Medical University Salzburg, Salzburg, Austria",

year = "2014",

doi = "10.1378/chest.14-0106",

language = "English",

volume = "146",

pages = "1274--1285",

journal = "CHEST ",

issn = "0012-3692",

number = "5",

}

Bonderman, D, Pretsch, I, Steringer-Mascherbauer, R, Jansa, P, Rosenkranz, S, Tufaro, C, Bojic, A, Lam, CSP, Frey, R, Ochan Kilama, M, Unger, S, Roessig, L & Lang, IM 2014, 'Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.', CHEST , Jg. 146, Nr. 5, S. 1274-1285. https://doi.org/10.1378/chest.14-0106

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. / Bonderman, Diana; Pretsch, Ingrid (Co-Autor/-in); Steringer-Mascherbauer, Regina et al.
in: CHEST , Jahrgang 146, Nr. 5, 2014, S. 1274-1285.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

AU - Bonderman, Diana

AU - Pretsch, Ingrid

AU - Steringer-Mascherbauer, Regina

AU - Jansa, Pavel

AU - Rosenkranz, Stephan

AU - Tufaro, Caroline

AU - Bojic, Andja

AU - Lam, Carolyn S P

AU - Frey, Reiner

AU - Ochan Kilama, Michael

AU - Unger, Sigrun

AU - Roessig, Lothar

AU - Lang, Irene M

N1 - the Department of Internal Medicine II (Cardiology) (Dr Pretsch), Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2014

Y1 - 2014

KW - PRESERVED EJECTION FRACTION

KW - SOLUBLE GUANYLATE-CYCLASE

KW - ENDOTHELIAL DYSFUNCTION

KW - PHOSPHODIESTERASE-5 INHIBITION

KW - NITRIC-OXIDE

KW - GUIDELINES

KW - COMMUNITY

KW - DIAGNOSIS

KW - GENDER

KW - TARGET

U2 - 10.1378/chest.14-0106

DO - 10.1378/chest.14-0106

M3 - Original Article

C2 - 24991733

SN - 0012-3692

VL - 146

SP - 1274

EP - 1285

JO - CHEST

JF - CHEST

IS - 5

ER -

Bonderman D, Pretsch I, Steringer-Mascherbauer R, Jansa P, Rosenkranz S, Tufaro C et al. Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. CHEST . 2014;146(5):1274-1285. doi: 10.1378/chest.14-0106